Literature DB >> 17338721

Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia.

David Lin1, Fermin Garcia, Jason Jacobson, Edward P Gerstenfeld, Sanjay Dixit, Ralph Verdino, David J Callans, Francis E Marchlinski.   

Abstract

BACKGROUND: Inappropriate sinus tachycardia (IST) is characterized by heart rate (HR) increase out of proportion to stress level. Radiofrequency (RF) modification of the sinus node (SN) is an accepted treatment modality for medically refractory IST. We describe a new technique using noncontact mapping and a saline irrigated catheter for SN modification.
METHODS: Seven consecutive patients with medically refractory IST were referred for ablation. Intrinsic heart rate (IHR) was calculated with complete autonomic blockade by atropine and propranolol. Isoproterenol (ISO) 1 mcg/min was initiated and increased to 10 mcg/min. Site of earliest activation was tagged at each dose of ISO once stable HR was achieved. RF ablation to target site of earliest activation at peak HR on ISO 10 mcg/min was performed. With any change in P-wave morphology, activation was reassessed and the new site of earliest activation targeted. Endpoint was a decrease in HR and change in P-wave morphology in lead III and aVF.
RESULTS: Five of seven patients had abnormal IHR. Mean number of RF lesions was 25 (10-52). All patients had either flattening of the P wave or development of negative P waves in leads III and aVF post RF associated with a decrease in HR of > or = 25% from baseline off ISO. A caudal shift of the site of early activation compared with baseline was observed. One patient who had a prior SN modification developed symptomatic intermittent junctional bradycardia and required an atrial pacemaker 2 weeks later. The other 6 patients in follow-up from 6 to 24 months had no further IST.
CONCLUSIONS: Noncontact mapping using the described technique in conjunction with the saline-cooled ablation catheter for SN modification in the treatment of IST may provide effective HR control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338721     DOI: 10.1111/j.1540-8159.2007.00655.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia.

Authors:  Sergio Hugo Ibarra-Cortez; Moisés Rodríguez-Mañero; Bahij Kreidieh; Paul Schurmann; Amish S Dave; Miguel Valderrábano
Journal:  Heart Rhythm       Date:  2016-01-21       Impact factor: 6.343

Review 2.  Catheter ablation of inappropriate sinus tachycardia.

Authors:  Carola Gianni; Luigi Di Biase; Sanghamitra Mohanty; Yalçın Gökoğlan; Mahmut F Güneş; Rodney Horton; Patrick M Hranitzky; J David Burkhardt; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2015-08-27       Impact factor: 1.900

Review 3.  Treatment of inappropriate sinus tachycardia with ivabradine.

Authors:  Martino Annamaria; Pier Paolo Lupo; Sara Foresti; Guido De Ambroggi; Ermenegildo de Ruvo; Luigi Sciarra; Riccardo Cappato; Leonardo Calo
Journal:  J Interv Card Electrophysiol       Date:  2015-10-14       Impact factor: 1.900

Review 4.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

5.  Inappropriate Sinus Tachycardia Diagnosed and Treated as Depression Successfully Treated by Radiofrequency Catheter Ablation.

Authors:  Akihiro Masumoto; Masao Takemoto; Takahiro Mito; Atsushi Tanaka; Yuki Kawano; Hiroshi Kumeda; Honsa Kang; Atsutoshi Matsuo; Satoru Hida; Teiji Okazaki; Kei-Ichiro Tayama; Kiyonobu Yoshitake; Kenichi Kosuga
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.